Skip to main navigation Skip to search Skip to main content

Real-world studies in psychiatry: Insights into antipsychotic-Associated breast cancer risk and their broader implications

  • Olivier Corbeil
  • , Itziar Montalvo
  • , Javier Labad
  • , Jurjen J. Luykx*
  • *Corresponding author for this work
  • Université Laval
  • Institut Universitaire en Santé Mentale de Québec
  • Parc Taulí Research and Innovation Institute
  • Autonomous University of Barcelona
  • Centro de Investigación Biomèdica en Red de Salud Mental (CIBERSAM)
  • Maresme Health Consortium
  • Amsterdam UMC - University of Amsterdam
  • GGZ inGeest Mental Health Care
  • Maastricht University

Research output: Contribution to journalReview articleAcademicpeer-review

25 Downloads (Pure)

Abstract

Real-world studies provide valuable insights into long-term outcomes across diverse populations. Here, we contextualise recent findings on the association between antipsychotic use and breast cancer risk in women with schizophrenia. We discuss clinical implications and the strengths and limitations of real-world studies in psychiatry. We conclude with future perspectives.

Original languageEnglish
Pages (from-to)7-9
Number of pages3
JournalBritish journal of psychiatry
Volume228
Issue number1
Early online date2025
DOIs
Publication statusPublished - 1 Jan 2026

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Psychiatry
  • antipsychotics
  • breast cancer
  • real-world studies
  • schizophrenia

Fingerprint

Dive into the research topics of 'Real-world studies in psychiatry: Insights into antipsychotic-Associated breast cancer risk and their broader implications'. Together they form a unique fingerprint.

Cite this